"DeltaPV aims to create awareness and educate the markets about the importance of pharmacovigilance. We are also working on automating the data that we obtain from our searches so that statistics will be available automatically to signal a drug safety problem immediately."

Dr. Seyfullah Dağıstanlı & Aytek Dağıstanlı

FOUNDER & BUSINESS DEVELOPMENT MANAGER, DELTAPV

March 17, 2020

Can you give an overview of DeltaPV?  

S.D: After I started working in the private sector I realized that many local companies lack the knowledge to manage their responsibilities in pharmacovigilance field. Small companies may not have the budget to invest in and implement a sound system. It was clear that local companies needed the assistance of experts. As a result, the market for contracted pharmacovigilance service companies emerged.

The pharmacovigilance market is projected to double by 2025 worldwide. How do you think this market will evolve in Turkey and are there any recent pieces of regulation that may impact on the demand side? 

S.D: From 2011 to 2014, most of DeltaPV’s clients were multinational companies who needed extra reporting, which they outsourced. In 2014, a new regulation, the Pharmacovigilance Directive, was implemented and awareness on the topic increased significantly. Within two-to-three months of the directive being implemented, we saw a significant increase in the demand for our services.

What are the core markets served by DeltaPV and how may these evolve in the future?

S.D: DeltaPV dominates the Turkish market and we hold approximately 90% of the market share. Internationally, we have three active focal points; one in the UK, one in Croatia and one in Kazakhstan. We aim to grow our footprint in developing countries and markets as we believe that we are a significant competitor due to our affordable prices and great industry knowledge.

A.D: Turkey has an advantage in terms of exports as many countries prefer Turkey for its relatively high quality work and cheap prices. Turkey also has a geographical and cultural advantage as it is located between Europe and Asia. Developing countries are important for all pharmacovigilance service providers, but being located in Turkey, we have the advantage of being able to be more cost competitive, we have a culturally diverse understanding, and we have an excellent developed infrastructure. Pharmacovigilance is very important and we have the aim to provide the best services in developing countries where awareness is now increasing. DeltaPV also takes on the responsibility to educate the market and to teach those who do not have the knowledge.  

What is the added value that DeltaPV brings to its clients?

A.D: DeltaPV’s main advantage is that we commit to understanding our client’s business and requirements. We offer the entire pharmacovigilance package to customers, but are also willing to provide only part of the package, according to our customer’s needs.

Our greatest asset is the software which enables DeltaPV to conduct literature screenings in any language which read from left to right. We can scan 370 local journals in a relatively short time. This is a great advantage in ensuring patient safety and DeltaPV is one of the only companies that have this capability. DeltaPV provides services to approximately 174 companies.

What is DeltaPV’s vision moving forward?

A.D: DeltaPV aims to create awareness and educate the markets about the importance of pharmacovigilance. We are also working on automating the data that we obtain from our searches so that statistics will be available automatically to signal a drug safety problem immediately.

S.D: Pharmacovigilance is important in understanding drugs’ behaviors and to increase the safety of the product. Reporting of adverse reactions allows for continuous monitoring of the medicinal product’s benefit/risk ratio. Side effects can also give an idea about a new indication or new possible product.  DeltaPV is bringing the science and technology together to offer the highest quality services to our customers at affordable prices. 

 

INTERVIEWS MORE INTERVIEWS

"There is a consensus that large new deposits like Escondida are rare, but the development of multiple medium-sized mines, possibly centralized around shared infrastructure, offers a significant opportunity."
"Our jurisdictional diversification is certainly a defining characteristic of Thor, but so is the fact that our projects are also diversified by stage of development."
"Port Houston’s strategic location and extensive services make it the leading gateway for waterborne trade between Latin America and the US."
"Paradigm lets us run the entire blast digitally before we even drill or lay out the shot. We can simulate a model for fly rock risk, predict ground vibrations, and evaluate how blasting might impact neighbors or nearby infrastructure."

RECENT PUBLICATIONS

Québec and Atlantic Canada Mining 2025

Québec and Atlantic Canada have traversed 2025 in an enviable position. Strong gold prices have buoyed balance sheets and investor sentiment, while global demand for critical minerals keeps the region firmly on the radar of international markets. At the same time, the provinces’ depth of mining expertise – from AI-driven exploration to advanced drilling, blasting, and geophysics – ensures that technological advantage is firmly on their side.

MORE PREVIOUSLY PUBLISHED

MACIG

"Our jurisdictional diversification is certainly a defining characteristic of Thor, but so is the fact that our projects are also diversified by stage of development."

SUBSCRIBE TO OUR NEWSLETTER